NCT04671706View on ClinicalTrials.gov

Belimumab in Patients With Systemic Lupus Erythematosus

Not yet recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

January 31, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Systemic Lupus Erythematosus
Trial Locations (1)

08036

Hospital Clinic Barcelona, Barcelona

All Listed Sponsors
lead

Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Fundación Española de Medicina

OTHER

NCT04671706 - Belimumab in Patients With Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter